Asset
BARICITINIB
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00902486 | phase2 | completed | 2009-05-01 | 2010-06-01 | Incyte Corporation | INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs |
FDA applications (0)
This company has no applications containing this asset.